Eplontersen pregnancy and breastfeeding safety study
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tracks the safety of eplontersen during pregnancy and breastfeeding by collecting reports from people who have taken it. It helps doctors understand any risks to the baby or mother.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child took eplontersen during pregnancy or while breastfeeding
- You or your child has a condition that eplontersen is approved to treat
- If you had a baby, any health problems in the first year of life that might be linked to eplontersen are reported
- You are willing to provide information and be contacted for follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who already took part in an earlier trial (D8450R00003) to see how safe eplontersen is over the long term. It also includes people who had a liver transplant or severe liver problems.
This is a long-term study to check the safety of eplontersen over time in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). It is mainly for people who already took the study medication before, or who joined an earlier related study and are doing well.
This program monitors the safety of the drug patisiran during pregnancy. If you have received patisiran around the time of pregnancy, it may help track any effects on you and your baby.
This study tracks the safety of the medicine TEGSEDI during pregnancy for women with hATTR-PN, a rare genetic nerve condition. It compares outcomes between those who took TEGSEDI while pregnant and those who did not, to better understand any risks.
This trial studies how safe and well bitopertin works over the long term for people with EPP. It mainly includes people who already finished an earlier bitopertin study, to keep tracking side effects and overall progress.
This study tracks pregnancy and baby outcomes in people who have been pregnant while taking tralokinumab, a medication for eczema. It compares those outcomes to other eczema treatment groups to help doctors understand potential risks or reassuring effects.
Hear when a new Transthyretin Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.